A phase II trial of intraperitoneal EGEN-001, an IL-12 plasmid formulated with PEG–PEI–cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: A Gynecologic Oncology Group study

✍ Scribed by Alvarez, Ronald D.; Sill, Michael W.; Davidson, Susan A.; Muller, Carolyn Y.; Bender, David P.; DeBernardo, Robert L.; Behbakht, Kian; Huh, Warner K.

• Book ID: 122978960
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 308 KB
• Volume: 133
• Category: Article
• ISSN: 0090-8258
• DOI: 10.1016/j.ygyno.2014.03.571